Cataract patients younger than 65 years at the time of surgery showed more stable self-reported and clinically evaluated visual function than an older comparator group at 10 years out, according to a study.
Source: Ocular Surgery News
The Massachusetts Eye and Ear Infirmary Cataract Surgery Trainer, a virtual training tool which helps to train physicians to perform cataract surgery, has been shown to enhance teaching in cataract surgery when compared to traditional teaching methods. The results of a multi-center study evaluating the program's effectiveness as a supplement to traditional teaching tools was published in the February issue of Ophthalmology.
Source: Medical News Today
Keith H. Baratz, MD, is Associate Professor in the Department of Ophthalmology at the Mayo Clinic School of Medicine in Rochester, MN and serves on the editorial board of Archives of Ophthalmology. He is also the former Residency Director and former Director of Research in Mayo’s Department of Ophthalmology.
Source: American Board of Ophthalmology
STAAR Surgical Company , a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, announced today regulatory approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) to market the Company's Visian Implantable Collamer® Lens (ICL) in Japan.
Source: STAAR Surgical Company
Source: ARVO
KOLOA, Hawaii — Although the study was not designed to evaluate risk of progression of age-related macular degeneration after cataract extraction, review of AREDS data provides additional information about the potential risk, according to a speaker here.
Source: OSN SuperSite
Bilateral implantation of an apodized diffractive aspheric multifocal IOL with +3.0 D add power resulted in patients achieving good visual results, spectacle independence and satisfaction, a study found.
Bausch & Lomb today announced that it is launching the Crystalens® AO, the first aberration-free accommodating intraocular lens (IOL) with aspheric optics to cataract surgeons worldwide. The announcement follows the recent FDA approval of this newest Bausch & Lomb surgical product. The Crystalens AO, combined with the successful Crystalens HD and the Crystalens Five-0, will further establish Crystalens as the market leader in the premium IOL market.
Source: Bausch & Lomb
Vissum has launched a large national research project — combining the forces of companies, public and private clinics, and research institutes — aimed at developing personalized and minimally invasive ophthalmology.
A new accommodating IOL design provided positive visual and refractive outcomes and was well-tolerated, according to data from the first human study of the implant.
Sponsored by
A 40 y.o. female pictured below comes to the office with swelling of both upper lids, mild shortness of breath and symptoms of dry eyes. One would expect to see as part of her work up:
You do not have JavaScript enabled or are using an older version of Adobe Flash. You can update your version of Adobe Flash here.
Feb 18 - Feb 21, 2010
FL (Palm Beach)
More Information
More Events
OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.
Learn more about writing